Cite
HARVARD Citation
Cui, L. et al. (2019). Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?. Annals of neurology. 86 (1), pp. 5-16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cui, L. et al. (2019). Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?. Annals of neurology. 86 (1), pp. 5-16. [Online].